Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Amyloids in bacterial inclusion bodies

  • Sánchez de Groot, Natalia|||0000-0002-0492-5532
  • Sabaté Lagunas, Raimon|||0000-0003-3894-2362
  • Ventura, Salvador|||0000-0002-9652-6351
Protein misfolding and aggregation into amyloid structures are associated with dozens of human diseases. Recent studies have provided compelling evidence for the existence of highly ordered, amyloid-like conformations in the insoluble inclusion bodies produced during heterologous protein expression in bacteria. Thus, amyloid aggregation seems to be an omnipresent process in both eukaryotic and prokaryotic organisms. Amyloid formation inside cell factories raises important safety concerns with regard to the toxicity and infectivity of recombinant proteins. Yet such findings also suggest that prokaryotic cells could be useful systems for studying how and why proteins aggregate in vivo, and they could also provide a biologically relevant background for screening therapeutic approaches to pathologic protein deposition.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Design, selection, and characterization of thioflavin-based intercalation compounds with metal chelating properties for application in alzheimer's disease

  • Rodriguez Rodriguez, Cristina|||0000-0002-3313-4422
  • Sánchez de Groot, Natalia|||0000-0002-0492-5532
  • Rimola, Albert|||0000-0002-9637-4554
  • Álvarez-Fernández, Alejandra|||0000-0002-1906-0180
  • Lloveras Monserrat, Vega|||0000-0002-9653-3340
  • Vidal-Gancedo, José|||0000-0002-1853-9675
  • Ventura, Salvador|||0000-0002-9652-6351
  • Vendrell Roca, Josep|||0000-0002-9378-4742
  • Sodupe, Mariona|||0000-0003-0276-0524
  • González Duarte, Pilar
Metal chelation is considered a rational therapeutic approach for interdicting Alzheimer's amyloid pathogenesis. At present, enhancing the targeting and efficacy of metal-ion chelating agents through ligand design is a main strategy in the development of the next generation of metal chelators. Inspired by the traditional dye Thioflavin-T, we have designed new multifunctional molecules that contain both amyloid binding and metal chelating properties. In silico techniques have enabled us to identify commercial compounds that enclose the designed molecular framework (M1), include potential antioxidant properties, facilitate the formation of iodine-labeled derivatives, and can be permeable through the blood-brain barrier. lodination reactions of the selected compounds, 2-(2-hydroxyphenyl)benzoxazole (HBX), 2-(2-hydroxyphe- nyl)benzothiazole (HBT), and 2-(2-aminophenyl)-1 H-benzimidazole (BM), have led to the corresponding iodinated derivatives HBXI, HBTI, and BMI, which have been characterized by X-ray diffraction. The chelating properties of the latter compounds toward Cu(ll) and Zn(ll) have been examined in the solid phase and in solution. The acidity constants of HBXI, HBTI, and BMI and the formation constants of the corresponding ML and ML2 complexes [M = Cu(ll), Zn(ll)] have been determined by UV-vis pH titrations. The calculated values for the overall formation constants for the ML 2 complexes indicate the suitability of the HBXI, HBTI, and BMI ligands for sequestering Cu(ll) and Zn(ll) metal ions present in freshly prepared solutions of β-amyloid (Aβ) peptide. This was confirmed by Aβ aggregation studies showing that these compounds are able to arrest the metal-promoted increase in amyloid fibril buildup. The fluorescence features of HBX, HBT, BM, and the corresponding iodinated derivatives, together with fluorescence microscopy studies on two types of pregrown fibrils, have shown that HBX and HBT compounds could behave as potential markers for the presence of amyloid fibrils, whereas HBXI and HBTI may be especially suitable for radioisotopic detection of Aβ deposits. Taken together, the results reported in this work show the potential of new multifunctional thioflavin-based chelating agents as Alzheimer's disease therapeutics.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Prediction of enzyme function by combining sequence similarity and protein interactions

  • Espadaler, Jordi
  • Eswar, Narayanan
  • Querol, Enrique
  • Avilés, Francesc Xavier
  • Sali, Andrej
  • Martí Renom, Marc A.
  • Oliva Miguel, Baldomero
Background: A number of studies have used protein interaction data alone for protein function prediction. Here, we introduce a computational approach for annotation of enzymes, based on the observation that similar protein sequences are more likely to perform the same function if they share similar interacting partners. Results: The method has been tested against the PSI-BLAST program using a set of 3,890 protein sequences from which interaction data was available. For protein sequences that align with at least 40% sequence identity to a known enzyme, the specificity of our method in predicting the first three EC digits increased from 80% to 90% at 80% coverage when compared to PSI-BLAST. Conclusion: Our method can also be used in proteins for which homologous sequences with known interacting partners can be detected. Thus, our method could increase 10% the specificity of genome-wide enzyme predictions based on sequence matching by PSI-BLAST alone., JE was supported by predoctoral fellowship from the Generalitat de Catalunya and CERBA (Spain). EQ acknowledges grants from the Spanish Ministerio de Educación y Ciencia (BIO2007-67904-C02-01). FXA acknowledges grants from the Spanish Ministerio de Educación y Ciencia (BIO2007-68046). AS acknowledges the financial support by the Sandler Family Supporting Foundation, IBM, HP, Netapps, and Intel for hardware gifts, and NIH grants GM74945, GM74929, GM71790, and GM54762. MAM-R acknowledges support from the Spanish Ministerio de Educación y Ciencia (BIO2007-66670). BO acknowledges grants from Generalitat de Catalunya (CIDEM), Spanish Ministerio de Educación y Ciencia (MEC BIO2005-00533 and PROFIT PSE-010000-2007-1) and by European Union INFOBIOMED-NoE (IST-507585) and @NEURIST (IST-2004-027703)
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Prediction of enzyme function by combining sequence similarity and protein interactions

  • Espadaler, Jordi
  • Eswar, Narayanan
  • Querol, Enrique
  • Avilés, Francesc Xavier
  • Sali, Andrej
  • Martí Renom, Marc A.
  • Oliva Miguel, Baldomero
Background: A number of studies have used protein interaction data alone for protein function prediction. Here, we introduce a computational approach for annotation of enzymes, based on the observation that similar protein sequences are more likely to perform the same function if they share similar interacting partners. Results: The method has been tested against the PSI-BLAST program using a set of 3,890 protein sequences from which interaction data was available. For protein sequences that align with at least 40% sequence identity to a known enzyme, the specificity of our method in predicting the first three EC digits increased from 80% to 90% at 80% coverage when compared to PSI-BLAST. Conclusion: Our method can also be used in proteins for which homologous sequences with known interacting partners can be detected. Thus, our method could increase 10% the specificity of genome-wide enzyme predictions based on sequence matching by PSI-BLAST alone., JE was supported by predoctoral fellowship from the Generalitat de Catalunya and CERBA (Spain). EQ acknowledges grants from the Spanish Ministerio de Educación y Ciencia (BIO2007-67904-C02-01). FXA acknowledges grants from the Spanish Ministerio de Educación y Ciencia (BIO2007-68046). AS acknowledges the financial support by the Sandler Family Supporting Foundation, IBM, HP, Netapps, and Intel for hardware gifts, and NIH grants GM74945, GM74929, GM71790, and GM54762. MAM-R acknowledges support from the Spanish Ministerio de Educación y Ciencia (BIO2007-66670). BO acknowledges grants from Generalitat de Catalunya (CIDEM), Spanish Ministerio de Educación y Ciencia (MEC BIO2005-00533 and PROFIT PSE-010000-2007-1) and by European Union INFOBIOMED-NoE (IST-507585) and @NEURIST (IST-2004-027703)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Direct interaction between a human digestive protease and the mucoadhesive poly(acrylic acid)

  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Fernández Fleischhauer, Daniel|||0000-0002-6221-152X
  • Comellas-Bigler, Mireia
  • Fernández-Recio, Juan|||0000-0002-3986-7686
  • Ventura, Salvador|||0000-0002-9652-6351
  • Avilés, Francesc Xavier|||0000-0002-1399-6789
  • Bode, Wolfram
  • Vendrell i Roca, Josep|||0000-0002-9378-4742
Carboxypeptidase A1 has been the subject of extensive research in the last 30 y and is one of the most widely studied zinc metalloenzymes. However, the three-dimensional structure of the human form of the enzyme is not yet available. This report describes the three-dimensional structure of human carboxypeptidase A1 (hCPA1) derived from crystals that belong to the tetragonal space group P43212 and diffract to 1.6 Å resolution. A description of the ternary complex hCPA1-Zn2+-poly(acrylic acid) is included as a model of the interaction of mucoadhesive polymers with proteases in the gastrointestinal tract. The direct mode of interaction between poly(acrylic acid) and the active site of the target protease was confirmed by in vitro inhibition assays. The structure was further analyzed in silico through the optimal docking-area method. The characterization of binding sites on the surface of hCPA1 and a comparison with other available carboxypeptidase structures provided further insights into the formation of multiprotein complexes and the activation mechanisms of carboxypeptidase zymogens. The high-resolution structure of hCPA1 provides an excellent template for the modelling of physiologically relevant carboxypeptidases and could also contribute to the design of specific agents for biomedical purposes.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Amyloid-like protein inclusions in tobacco transgenic plants

  • Villar-Piqué, Anna
  • Sabaté Lagunas, Raimon|||0000-0003-3894-2362
  • Lopera Ortega, Oriol
  • Gibert Amat, Jordi
  • Torné, Josep M.
  • Santos, Mireya
  • Ventura, Salvador|||0000-0002-9652-6351
The formation of insoluble protein deposits in human tissues is linked to the onset of more than 40 different disorders, ranging from dementia to diabetes. In these diseases, the proteins usually self-assemble into ordered β-sheet enriched aggregates known as amyloid fibrils. Here we study the structure of the inclusions formed by maize transglutaminase (TGZ) in the chloroplasts of tobacco transplastomic plants and demonstrate that they have an amyloid-like nature. Together with the evidence of amyloid structures in bacteria and fungi our data argue that amyloid formation is likely a ubiquitous process occurring across the different kingdoms of life. The discovery of amyloid conformations inside inclusions of genetically modified plants might have implications regarding their use for human applications.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Prediction of enzyme function by combining sequence similarity and protein interactions

  • Espadaler Mazo, Jordi|||0000-0002-0128-8363
  • Eswar, Narayanan
  • Querol Murillo, Enrique|||0000-0002-3658-3434
  • Avilés, Francesc Xavier|||0000-0002-1399-6789
  • Sali, Andrej|||0000-0003-0435-6197
  • Martí Renom, Marc A.
  • Oliva Miguel, Baldomero|||0000-0003-0702-0250
Background: A number of studies have used protein interaction data alone for protein function prediction. Here, we introduce a computational approach for annotation of enzymes, based on the observation that similar protein sequences are more likely to perform the same function if they share similar interacting partners. Results: The method has been tested against the PSI-BLAST program using a set of 3,890 protein sequences from which interaction data was available. For protein sequences that align with at least 40% sequence identity to a known enzyme, the specificity of our method in predicting the first three EC digits increased from 80% to 90% at 80% coverage when compared to PSI-BLAST. Conclusion: Our method can also be used in proteins for which homologous sequences with known interacting partners can be detected. Thus, our method could increase 10% the specificity of genome-wide enzyme predictions based on sequence matching by PSI-BLAST alone.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase A

  • Fernández Fleischhauer, Daniel|||0000-0002-6221-152X
  • Boix, Ester|||0000-0003-1790-2142
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Avilés, Francesc Xavier|||0000-0002-1399-6789
  • Vendrell Roca, Josep|||0000-0002-9378-4742
A high-resolution carboxypeptidase-Zn 2+ -citrate complex was studied by X-ray diffraction and enzyme kinetics for the first time. The citrate molecule acts as a competitive inhibitor of this benchmark zinc-dependent peptidase, chelating the catalytic zinc ion in the active site of the enzyme and inducing a conformational change such that carboxypeptidase adopts the conformation expected to occur by substrate binding. Citrate adopts an extended conformation with half of the molecule facing the zinc ion, while the other half is docked in the S1' hydrophobic specificity pocket of the enzyme, in contrast with the binding mode expected for a substrate like phenylalanine or a peptidomimetic inhibitor like benzylsuccinic acid. Combined structural and enzymatic analysis describes the characteristics of the binding of this ligand that, acting against physiologically relevant zinc-dependent proteases, may serve as a general model in the design of new drug-protecting molecules for the oral delivery of drugs of peptide origin.